Compare REAL & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REAL | ALVO |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 2019 | N/A |
| Metric | REAL | ALVO |
|---|---|---|
| Price | $16.95 | $4.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $16.00 | $9.25 |
| AVG Volume (30 Days) | ★ 2.7M | 560.2K |
| Earning Date | 02-19-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | ★ $662,789,000.00 | $573,350,000.00 |
| Revenue This Year | $17.10 | $20.85 |
| Revenue Next Year | $10.90 | $44.49 |
| P/E Ratio | ★ N/A | $20.53 |
| Revenue Growth | 14.30 | ★ 45.55 |
| 52 Week Low | $4.61 | $4.32 |
| 52 Week High | $16.90 | $13.70 |
| Indicator | REAL | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 69.44 | 44.75 |
| Support Level | $15.67 | $4.61 |
| Resistance Level | $16.71 | $4.96 |
| Average True Range (ATR) | 0.75 | 0.26 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 93.28 | 46.41 |
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.